In contrast, Zhao et al. suggested that ApoE2 is associated with increased tau pathology relative to ApoE3 or ApoE4 in primary tauopathies such as progressive supranuclear palsy and corticobasal degeneration42. Here, MAPT is linked to progressive supranuclear palsy.